Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$11.05 - $12.72 $114,411 - $131,702
10,354 New
10,354 $119,000
Q4 2021

Feb 14, 2022

SELL
$10.86 - $13.95 $205,568 - $264,059
-18,929 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$11.92 - $13.92 $225,633 - $263,491
18,929 New
18,929 $247,000
Q2 2021

Aug 16, 2021

SELL
$10.16 - $13.11 $148,610 - $191,759
-14,627 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$9.04 - $11.86 $132,228 - $173,476
14,627 New
14,627 $164,000
Q2 2018

Aug 14, 2018

SELL
$11.83 - $16.2 $166,128 - $227,496
-14,043 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$11.13 - $13.63 $156,298 - $191,406
14,043 New
14,043 $217,000

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $682M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.